Related Experiment Video
Updated: Sep 14, 2025
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
Published on: April 7, 2023
Gut microbiota changes in postmenopausal women with low bone density linked to serum amino acid metabolism
Adriana Becerra-Cervera1,2, Rogelio F Jiménez-Ortega3,4, Diana I Aparicio-Bautista1
1Laboratorio de Genómica del Metabolismo Óseo, Instituto Nacional de Medicina Genómica (INMEGEN), Mexico City, Mexico.
Background:
The gut microbiota (GM) has been linked to changes in bone mineral density (BMD), potentially contributing to the development of osteopenia or osteoporosis. Although the relationship between specific bacterial taxa and bone remodeling has been documented in various populations, data on the Mexican population remain limited. This study aimed to analyze the changes in the taxonomic composition of GM associated with low BMD (osteopenia/osteoporosis) and explore potential mechanisms influencing bone metabolism in Mexican postmenopausal women.
Methods:
BMD was measured by dual-energy X-ray absorptiometry. GM composition was analyzed through 16S rRNA amplicon sequencing in Mexican postmenopausal women. Metabolic functions were predicted using PICRUSt2 based on KEGG pathways at hierarchy level 3. Serum amino acid (AA) concentrations were measured in a sub-sample using tandem mass spectrometry.
Results:
Our findings indicated that beta diversity significantly differed among BMD groups (p<0.05). Women with low BMD showed higher relative abundances of Bacteroides, Parabacteroides, Barnesiella, Odoribacter, Sutterella, Butyricimonas, Coprobacter, Angelakisiella, and Oscillibacter. Functional prediction revealed differences in alanine, valine, leucine, and methionine-related metabolic pathways. These findings were supported by lower serum concentrations of valine, leucine, and methionine in the low BMD group compared to the normal BMD group (p<0.05).
Conclusion:
This study provides evidence of the relationship between GM composition and AA concentrations with changes in BMD. These findings highlight promising areas for the development of potential therapeutic interventions.
More Related Videos
07:15An In Vitro Batch-culture Model to Estimate the Effects of Interventional Regimens on Human Fecal Microbiota
Published on: July 31, 2019
06:59Author Spotlight: An Economic and Efficient Method for Quantitative Evaluation of Bone Microarchitecture in a Murine Osteoporosis Model
Published on: September 8, 2023
Related Concept Videos
01:29Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
01:25Role of Vitamins in Maintaining Bone Health
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
01:40Bone Remodeling
01:31Essential Minerals for Bone Health
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
01:17Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
01:31Osteoclasts in Bone Remodeling